The doses are the first of 70,000 allocated for Kinshasa as experts warn of the virus's exponential spread.

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

Imunizante aprovado mira a cepa Zaire, não a Bundibugyo